Back

Fibroblast-specific deletion of ERBB4 impairs cardiac regeneration in neonatal mice

2 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Matrix and fibrosis: experimental aspects Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Siel Van Den Bogaert

University of Antwerp, Antwerp (Belgium)

7 More presentations in this session

Presentation thumbnail
Cancer ameliorates cardiac dysfunction and suppresses fibrosis in a mouse model for Duchenne muscular dystrophy
Mrs L. Achlaug (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Vitamin D in cardiac fibroblasts: new evidence for a TRP-mediated non-genomic pathway
Associate Professor Y. Saliba (Beirut, LB)
Abstract Slides Video
Presentation thumbnail
Anti-fibrotic effects of the sirt6-activator mdl-800 in cardiac stromal cells
Doctor C. Cozzolino (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Dysfunctional atrial fibroblast processing of filamin A in atrial fibrillation.
Mr A. Johnston (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Investigation of the usefulness of collagen peptide in intramyocardial injection of human iPS cell-derived cardiomyocytes
Mr J. Iida (Kobe, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Matrix and fibrosis: experimental aspects

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
thumbnail
Congress Presentation
Dynamic transition of cardiac fibroblasts contributes critically to cardiac regeneration
thumbnail
Congress Presentation
A novel ERBB4 agonist attenuates cardiac remodelling after myocardial infarction in a sex-specific manner

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources